Subscribe Now!

Which Segment of Pharmaceutical Company will Bring Good Fortune?

Important Segments to track growth for Pharma Companies

Shuchi.P.Nahar

Investments in the global pharmaceuticals sector to increase to over $1,400 billion over the next three years, driven by a number of new medicines. With healthy R&D spending going forward, the Contract Research and Manufacturing (CRAMS) segment offers growth opportunities to Indian companiesChange in regulations around generic approvals will help Indian companies to increase penetration in Chinese markets, which will improve margin expansion. 

What are CRAMS ? 

CRAMS is defined as the process of outsourcing research services/ product manufacturing activities to organizations which can provide the service at a low cost. CRAMS basically consists of the following two activities: contract research and contract manufacturing. CRAMS is mainly used in the Pharmaceutical and Biotechnology sectors that require extensive R&D and large-scale manufacturing facilities. It is expected that the demand for contract research and contract manufacturing is expected to increase in India in the future.

Future for Pharmaceutical Companies 

Developing countries such as India, China, Mexico, and Brazil are witnessing significant improvements in their healthcare infrastructure and technological innovations in their drug development processes. As a result, several pharmaceutical companies from developed countries are outsourcing the research and manufacturing operations to the vendors in such countries. The availability of labor at a comparatively lower price is one of the critical reasons for the growing popularity of outsourcing these processes. 

Moreover, the rising number of US FDA-approved manufacturing plants in developing countries also encourages outsourcing. These factors will augment the growth of the pharmaceutical CRAM market during the forecast period.

Rising demand for generic formulations, increased investments in pharmaceutical Research & Development and advanced manufacturing technologies by contract development and manufacturing organization (CDMO’s) are key factors contributing to the high CAGR of Pharmaceutical Contract Manufacturing market during the forecast period.

Market Size – USD 82430.9 Million in 2018, Market Growth – CAGR of 7.2 %, Market Trends – Increasing outsourcing of clinical trials, increasing CDMO’s manufacturing footprint in Asia


The pharmaceutical industry uses outsourcing services from providers in the form of contract research organizations (CROs) and contract manufacturing organizations (CMOs). Comprehensive single-source provider from drug development through commercial manufacture has emerged in recent years. 

It is known as contract research and manufacturing services (CRAMS), or contract development and manufacturing organizations (CDMO). Pharmaceutical Contract Manufacturing organizations are a response to the competitive international nature of the pharmaceutical market as well as the increasing demand for outsourced services.

Owing to a wide ranging product mix consisting of high-end research services, biologics, and complex technology services, all offered at a low cost, contract manufacture and research services (CRAMS) industry has witnessed tremendous growth in the Indian subcontinent. 

With externalization of research to emerging markets, India presents a strong case for outsourcing research and manufacturing.

Picture Credit: RedNewswire

PHARMACEUTICAL CONTRACT MANUFACTURING MARKET TO REACH USD 144958.8 MILLION BY 2026 GROWING AT A CAGR OF 7.2%

The pharmaceutical industry has undergone significant changes over the years, in terms of technology for R&D of drugs. One of these significant advances include the use of analytics for identifying various essential aspects of research. The use of analytical tools for clinical data synthesis helps companies to quicken the drug development process. 

Big data helps to avoid the high cost of adverse events. It also allows companies to keep a record of patients for long durations, which enables regular monitoring after treatment. The advent of big data will benefit CROs as it makes the process more efficient.
With lower cost manufacturers capturing a major portion of the market, India is in a pole position in the area of dosage form and end-to-end efficiency in outsourcing.

Industry experts find a tectonic shift across the contract research organisation landscape with several key pharma players now outsourcing their early drug development activities covering pre-clinical and early phase research to some of the leading CRO players in the market which was earlier handled by pharma companies themselves.

With externalization of research to emerging markets, India presents a strong case for outsourcing research and manufacturing. Whilst contract manufacturing is expected to garner a larger share of revenues in the range of over 50-60 per cent, the country is also witnessing a simultaneous contribution from the contract research services capturing rest of the CRAMS services and over 20 per cent of the APAC CRO market. 

The Indian government policies to encourage exports and support the growing R&D through several tax benefits and have allowed the country to be on the forefront of contract research and manufacturing services.

India is amongst the preferred destinations for outsourcing of research as well as manufacturing activities. New age CRAMS providers are able to cater to not just the pharmaceutical clients, but also biotech, agrochemicals, nutrition, animal health, consumer goods and others. This has opened up wider growth opportunities for the sector. At present, there is very less innovator manufacturing happening out of India as contract manufacturing


Indian CRAMS companies hold a competitive edge across the global pharmaceutical industry in being the most preferred partners for drug development and manufacturing. Owing to a wide ranging product mix consisting of high-end research services, biologics, and complex technology services, all offered at a low cost, CRAMS industry has witnessed tremendous growth in the Indian subcontinent.

Global CRAMS market is highly fragmented with over 1000 players with SEA countries such as India, China, Japan, Singapore, Malaysia etc. expected to show a robust double digit growth. In most cases, process development and clinical research are the majorly opted services from CRAMS players. According to the Indian Government, by 2020, India would be one of the top five pharmaceutical innovation hubs with one out of every five to 10 drugs discovered in India. Despite positioning as the Go To market, China stands strong as a key contender especially in the field of generics manufacturing. 

For example, in June 2019, China’s National Health Commission published their first list of 34 drugs which are off patent or nearing patent expiration and have no generic drug counterpart. This in turn is encouraging local pharma companies to make generic drugs, under the drug regulator’s priority review pathway, which until now has mostly been handed to innovative drugs. Hence, we expect Asia Pacific to stay at the forefront of the CRAMS industry with India and China leading the charts.

Conclusion:

Global Pharmatech said that contract manufacturing for the Indian market is a challenging space. Margins are low or non-existent. This is particularly true for products under price control. Manufacturers who have large -scale operations which are run efficiently may make a profit but it is probably still below reasonable return on investment. 

Contract manufacturing for the US and other regulated markets is relatively more attractive but this requires investment in facilities, people and systems to maintain regulatory approvals. Companies which maintain their compliance status can continue to earn good returns even as pure CDMO.

Sources :Pharmabizz
                Data and reports
                Rednews Letters
                Pharma research Report
             

                                     SHUCHI.P.NAHAR

Comments

  1. Low cost manufacturing of generics, supplements, intermediaries, medical devices and many other pharmaceutical exporters in India have engaged many foreign investments to set up new production plants. This has led to a consistent growth in the country’s revenue production. Backing the plan, the industry has also gained constant support from the government as it generates employment and contributes to the country’s GDP.

    ReplyDelete
  2. The nation needs quality healthcare and this means that the pharma industry needs to develop faster. The main problem that is faced by the pharma manufacturer India is the lack of research components and also the lack of good manufacturing practices in real-time

    ReplyDelete
  3. Contract manufacturing is an outsourcing of certain production activities that were previously performed by the manufacturer to a third-party. please visit pintuu.com for more information.contract manufacturing

    ReplyDelete
  4. Wow amazing i saw the article with execution models you had posted. It was such informative. Really its a wonderful article. Thank you for sharing and please keep update like this type of article because i want to learn more relevant to this topic.
    Calcium Oxide 40.5 % manufacturer in maharashtra

    ReplyDelete
  5. We offer consistent temperature-controlled pharmaceutical warehousing facilities with secure storage & capacity with the assurance of the quality of medicines.

    ReplyDelete
  6. I am thankful to you for sharing this plethora of useful information. I found this resource utmost beneficial for me. Thanks a lot for hard work. order Fentanyl online

    ReplyDelete
  7. We are a genuine and reputed online directory which is offering best pharmaceutical third party manufacturing products in India
    ,Chandigarh, Punjab, baddi, Parwanoo, Nalagarh, Gujarat for pharmaceutical range and formulation with approved by the GMP and WHO guideline.

    ReplyDelete
  8. This comment has been removed by the author.

    ReplyDelete
  9. Finally, got to know how to track pharma company growth. Thanks for sharing this blog. Have used your technique and came into conclusion that Medicef Pharma is the best pharma manufacturer in India. Their high in quality and unique products makes them stand out in the market.

    ReplyDelete
  10. Thank so so much for this info. I just started a new blog from the scratch and hopping i will soon become a blogger like you.

    What is Third-Party Pharma Manufacturing?

    ReplyDelete
  11. ,Awesome blog. Thanks for sharing informative content. Safexpress is one of the best pharma logistics services provider company in India. when you are require this type services. Please call 1800113113 and get more information.

    ReplyDelete
  12. This comment has been removed by the author.

    ReplyDelete
  13. Thank you for conveying this excellent transmission. I discovered this writing and got some applicable components that were very helpful for me. Top Pharma Companies in Uttar Pradesh

    ReplyDelete
  14. Interesting blog post thanks for sharing with us. I really enjoyed reading it. The information was very useful. Try to post this kind of useful content in blog posts. I appreciated your work. Thank you.
    Trade Maantra | Pharma Franchise | Third Party Pharma Manufacturer | PCD Pharma

    ReplyDelete
  15. this blog is awsome! thanks for sharing this important blog with us
    Third Party Manufacturing For Derma Products

    ReplyDelete
  16. Nice Article! thanks for sharing this imformative article with us .keep it up

    Pharma Franchise in Ahmedabad

    ReplyDelete
  17. Thanks for sharing this article, very informative blog. We are Best customized erp software development company in chennai

    ReplyDelete
  18. Very interesting, you have done a good job and thanks for sharing such a good blogerp software in chennai

    ReplyDelete
  19. Thanks for sharing this useful information.

    Are you looking for pharma automation services? Contact ALS Logistic Solutions. They being your reliable partner for advanced pharma automation and logistics solutions specialize in providing pharmaceutical supply chain solutions that are both efficient and secure for the pharmaceutical industries. They assure seamless, compliant, and cost-effective pharma product distribution with our team of professionals with their end-to-end Pharma logistics solutions to ensure product integrity and timely delivery.

    ReplyDelete
  20. This comment has been removed by the author.

    ReplyDelete
  21. As the pharma contracting landscape continues to evolve, India's CRAMS industry stands as a beacon of innovation and cost-effectiveness. The interplay of analytics, government support, and the dynamic Asia-Pacific market propels India and China to the forefront of the global CRAMS industry, promising continued growth and excellence.

    ReplyDelete
  22. Nice blog which expresses the efficiency of medial product development by Contract Manufacturer Partners in USA which will lead to success in Pharma Medical Industry.

    ReplyDelete
  23. This blog offers valuable insights into key growth factors for pharmacy companies in contract manufacturing partners in USA. Emphasizing regulatory compliance, technology adoption, and supply chain resilience, the article highlights the need for strategic partnerships beyond transactions. A concise and informative read for pharmaceutical businesses navigating the complexities of the evolving industry landscape.

    ReplyDelete
  24. I find your blog quite captivating and beneficial. Ikon remedies is best pharma manufacturer in India with fast delivery ,offers a wide range of neuro care products. Our list contains over 1000+ products. Contact us now!

    ReplyDelete
  25. I find your blog quite captivating and beneficial. Innovative Pharma is Pharma Manufacturer in India.For the past decade, Innovative Pharmaceuticals has been actively nurturing communities across India and has emerged as one of the leading pharmaceutical companies experiencing significant growth.

    ReplyDelete
  26. This comment has been removed by the author.

    ReplyDelete
  27. Great Blog!

    This blog is a goldmine of insights on the key growth segments for pharmaceutical companies! Identifying and tracking these segments is undeniably crucial in navigating the ever-evolving landscape of the pharma industry.

    Also Check: Best Pharma Private Level Manufacturers in United Kingdom

    ReplyDelete
  28. Nice blog on medial product development by Contract Manufacturing Partners in USA for Pharma Medical Industry.

    ReplyDelete

Post a Comment

Most Favorite Reads!

Ethanol - Demand, Production, Opportunities & Production Projections (Part-2)

Ethanol - Demand, Market Size, Opportunities & New Goverment Policies (Part-2)

Ethanol - Demand, Market Size, Opportunities & New Goverment Policies (Part-1)

Nutraceuticals - The Next Gem of Healthcare Sector

Laurus Labs - Result Update Q4FY21 & Full Year FY21